conivaptan: Clinical Trials

7 trials of conivaptan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 withdrawn. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Terminated 2, Withdrawn 1

Follow conivaptan: new trials by email Literature Review of conivaptan trials Research Report on conivaptan

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia
Conivaptan hydrochloride, Placebo - Hyponatremia
Phase 3TerminatedCumberland Pharmaceuticals42012-02-012016-03-01
Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)
conivaptan, placebo - Hyponatremia, Acute Decompensated Heart Failure
Phase 3TerminatedCumberland Pharmaceuticals92009-04-012014-05-15
Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
Conivaptan, D5 - Hyponatremia
Phase 3WithdrawnColumbia University2008-05-012015-03-06
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Conivaptan, Placebo - Hyponatremia
Phase 3CompletedCumberland Pharmaceuticals502007-04-012014-05-15
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
conivaptan - Hyponatremia
Phase 3CompletedCumberland Pharmaceuticals2512004-02-012014-05-02
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
YM087 - Hyponatremia
Phase 3CompletedCumberland Pharmaceuticals842000-08-012014-05-02
Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
YM087 oral - Hyponatremia
Phase 3CompletedCumberland Pharmaceuticals832000-01-012014-05-02

Conditions studied

Hyponatremia (7)  ·  Edema (2)  ·  Diabetes Insipidus (1)  ·  Trauma, Nervous System (1)

Sponsors

Cumberland Pharmaceuticals (6)  ·  Columbia University (1)

Countries

United States (5)  ·  India (2)  ·  Israel (2)  ·  South Africa (2)  ·  Belgium (1)  ·  Canada (1)  ·  Colombia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Art Wheeler, MD (6)  ·  Stephan A. Mayer, MD (1)